Malachi Charbonneau Named as medaptus General Manager
BOSTON, May 20, 2021 /PRNewswire/ -- medaptus today announced that Malachi Charbonneau has been appointed as General Manager. Charbonneau will be...
News
New App, TeleHome, Connects Hospitalized COVID Patients With Loved Ones Through Virtual Visitations
EATONTOWN, N.J., May 20, 2021 /PRNewswire/ -- With a mission of connecting isolated COVID-19 patients to their loved ones, Caregility...
2021 ASCO Annual Meeting Publishes Two Abstracts Based on Real-World Patient Data Generated from Belong.Life’s Connected Health Platform
NEW YORK, May 20, 2021 /PRNewswire/ -- Belong.Life, developer of social and professional networks for managing and navigating diseases, and the...
DNA Script Advances Evaluation Program for the SYNTAX System, the First Benchtop DNA Printer Powered By Enzymatic Synthesis
The SYNTAX System Delivers DNA On Demand to Enable Labs to Control Their Workflow, Innovate Faster SOUTH SAN FRANCISCO, Calif.,...
GATC’s Predictive Multiomics Technology Can Improve Human Health
DALLAS, TX / ACCESSWIRE / May 21, 2021 / Imagine knowing what effect on a person's unique DNA has on contracting...
CGTN：China makes new pledges to help developing countries defeat COVID-19
BEIJING, May 21, 2021 /PRNewswire/ -- China on Friday announced several new measures to help developing countries tackle the COVID-19...
Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM
ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 21, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on...
Core One Labs Provides Clarification on Trading Activity
VANCOUVER, BC / ACCESSWIRE / May 21, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62, WKN:A2P8K3) (the "Company" or "Core...
MorphoSys To Participate in UBS Global Healthcare Conference
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 21, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that Jean-Paul Kress, M.D., the company's...
SANUWAVE Health and JV Partner Diversa S.A. Announce Distribution Agreement with Grupo Suprimed
SUWANEE, GA / ACCESSWIRE / May 21, 2021 / SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation wound care...
AG Mednet Names Michael Svinte Chief Commercial Officer, Will Grow Commercial Team Globally
BOSTON, MA / ACCESSWIRE / May 21, 2021 / AG Mednet, a technology company with a mission to speed medical...
Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
SAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company...
Université de Sherbrooke and deutraMed, a KEY DH Technologies’ Subsidiary, Accelerate $500,000 mRNA Vaccine Stabilization Technology Project
Collaboration Seeks To Alleviate Cold Storage Requirements for mRNA COVID Vaccines, Enhance Other Medical Therapeutics SHERBROOKE, QC and COLLINGWOOD, ON...
Correction: Coloplast A/S – Trading in Coloplast shares by board members, executives or associated persons
Please see enclosed pdf. The transaction concerns purchase of shares. Attachment 2105021_trading_in_shares_GL_corrected
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency
European Commission decision anticipated in JulyBOSTON, May 21, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical...
Albireo Receives Positive CHMP Opinion for Bylvay™ (odevixibat) for Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)
– Bylvay has the potential to become first approved drug to treat all forms of PFIC – – CHMP opinion...
Zymergen to Present at UBS Global Healthcare Virtual Conference
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming...
Myovant Sciences Receives Positive CHMP Opinion for RYEQO® (Relugolix Combination Tablet) for the Treatment of Women With Uterine Fibroids
CHMP opinion recommending approval based on data from the Phase 3 LIBERTY program in women with uterine fibroidsGedeon Richter will...
Share issue / transfer and annulment of shares in connection with reduction of the quantity of shares in Nexstim Plc
Company announcement, Helsinki, 21 May 2021 at 3:30 PM (EEST) Share issue / transfer and annulment of shares in connection...
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Brings Best-in-Class Team to Psychedelics Development
NEW YORK, May 21, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announces the availability of...